1315 Capital acquires Argonaut’s life sciences and diagnostics unit

Published on September 10, 2026

The divested unit, now operating independently as Aluris Sciences, provides contract manufacturing for life sciences, diagnostics and combination drug product customers from formulation through commercial production.

The post 1315 Capital acquires Argonaut’s life sciences and diagnostics unit appeared first on PE Hub.

Continue reading on website
Other news

Firms failing to address climate losses due to data shortfalls, survey finds

September 10, 2026
Capgemini and Sweep survey of 1,000 business leaders reveals 94% have taken financial hit from climate events in past two years.

ESG round-up: ECON committee approves EU Parliament’s SFDR position

September 10, 2026
Private market managers upping focus on biodiversity, survey finds – Article 9 funds saw outflows in Q2.